Merck Wins First Femur-Related Fosamax Suit
Merck & Co. on Monday triumphed in a New Jersey bellwether trial over femur fractures allegedly caused by its bone drug Fosamax, after a jury ruled that the nature of the...To view the full article, register now.
Already a subscriber? Click here to view full article